SLNO - SOLENO THERAPEUTICS INC
39.68
1.110 2.797%
Share volume: 1,756,358
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$38.57
1.11
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-07-2024 | 11-06-2024 | 02-28-2025 | 05-07-2025 | 08-06-2025 | 11-04-2025 | 02-25-2026 | |
| Assets | |||||||||
| Total Assets | 168.837 M | 304.131 M | 296.706 M | 330.972 M | 318.092 M | 332.306 M | 599.895 M | 563.830 M | |
| Current Assets | 151.223 M | 267.502 M | 258.199 M | 293.889 M | 308.915 M | 316.789 M | 534.853 M | 355.814 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 2.355 M | 6.674 M | 15.024 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 106.780 M | 209.099 M | 208.363 M | 203.509 M | 208.619 M | 210.344 M | 252.272 M | 235.366 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 42.847 M | 57.024 M | 48.413 M | 87.928 M | 81.331 M | 76.497 M | 246.662 M | 70.106 M | |
| Total Non-current Assets | 8.821 M | 28.482 M | 27.945 M | 27.211 M | 0.000 | 7.002 M | 57.148 M | 200.616 M | |
| Property Plant Equipment | 27.000 K | 19.000 K | 196.000 K | 186.000 K | 173.000 K | 166.000 K | 150.000 K | 185.000 K | |
| Other Assets | 17.587 M | 36.610 M | 38.311 M | 36.897 M | 9.004 M | 15.351 M | 64.892 M | 207.831 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 168.837 M | 304.131 M | 296.706 M | 330.972 M | 318.092 M | 332.306 M | 599.895 M | 563.830 M | |
| Total liabilities | 25.451 M | 23.374 M | 32.007 M | 85.859 M | 85.831 M | 92.166 M | 105.090 M | 113.715 M | |
| Total current liabilities | 13.464 M | 9.150 M | 14.962 M | 18.747 M | 15.731 M | 20.943 M | 33.253 M | 61.363 M | |
| Accounts Payable | 8.022 M | 3.716 M | 6.243 M | 8.882 M | 5.483 M | 6.216 M | 8.145 M | 12.435 M | |
| Other liabilities | 11.987 M | 14.224 M | 17.045 M | 17.284 M | 20.264 M | 21.378 M | 21.983 M | 2.489 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 49.828 M | 49.836 M | 49.845 M | 49.854 M | 49.863 M | |
| Other liabilities | 11.987 M | 14.224 M | 17.045 M | 17.284 M | 20.264 M | 21.378 M | 21.983 M | 2.489 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 143.386 M | 280.757 M | 264.699 M | 245.113 M | 232.261 M | 240.140 M | 494.805 M | 450.115 M | |
| Common stock | 441.300 M | 600.572 M | 660.082 M | 697.012 M | 728.068 M | 740.796 M | 969.173 M | 881.070 M | |
| Retained earnings | -297.808 M | -319.662 M | -396.278 M | -452.260 M | -496.033 M | -500.741 M | -474.728 M | -431.370 M |